New mesh technique aims to stop hiatal hernias from coming back
NCT ID NCT07251010
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests a new surgical method called Alinasser's technique for repairing symptomatic hiatal hernia. The procedure uses a mesh to rebuild the ligament that normally holds the esophagus in place, aiming to reduce the chance of hernia recurrence. Sixty adults who have not responded to medical treatment will be randomly assigned to receive either the new technique or the standard repair. The main goal is to see if the new approach lowers the rate of hernia coming back, as seen on imaging or endoscopy.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- surgical procedure (Alinasser's technique of laparoscopic hiatal hernia repair with mesh)
- What this could lead to
- If successful, this new surgical technique could lower the chance of hiatal hernia coming back after surgery, improving long-term outcomes for patients.
- What could go wrong
- This is a small early-stage trial with only 60 participants, so results may not apply to everyone. The new technique involves mesh, which carries risks like infection or erosion.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Dec 2025
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
* Eligibility criteria have been reformatted as follows: #Inclusion Criteria: * Adult patients (≥18 years) * Symptomatic hiatus hernia * Primary hiatus hernia * Not responding to medical treatment #Exclusion Criteria: * Children (\<18 years) * Recurrent hiatus hernia * Post-bariatric surgery * Pregnancy * Crohn's disease * Emergency surgery cases
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gastreoesophageal reflux disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Asser Health Cluster
Abhā, 'Asir Region, 62521, Saudi Arabia
More trials for these conditions
Other studies related to the condition(s) this trial covers.